Inhibition of microRNA-449a prevents IL-1β-induced cartilage destruction via SIRT1

Osteoarthritis and Cartilage

Volumn 24, Issue 12, 2016, Pages 2153-2161

  Park, K W ^a,b   Lee, K M ^a,b   Yoon, D S ^a   Park, K H ^c   Choi, W J ^a   Lee, J W ^a,b   Kim, S H ^d  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c CHA University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Chondrocytes; IL 1 ; microRNA 449a; Osteoarthritis; SIRT1

Indexed keywords

ADAMTS1 PROTEIN; COLLAGEN TYPE 2; COLLAGENASE 3; INTERLEUKIN 1BETA; MESSENGER RNA; MICRORNA; MICRORNA 449A; SIRTUIN 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BINDING SITE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CARTILAGE; CELL CULTURE; CHONDROCYTE;

CARTILAGE; CELLS, CULTURED; CHONDROCYTES; HUMANS; INTERLEUKIN-1BETA; MICRORNAS;

EID: 84979711157     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2016.07.002     Document Type: Article

References (48)

1. 1 Malfait, A.M., Osteoarthritis year in review 2015: biology. Osteoarthritis Cartilage 24:1 (2016), 21–26.
2. 2 Shane Anderson, A., Loeser, R.F., Why is osteoarthritis an age-related disease?. Best Pract Res Clin Rheumatol 24:1 (2010), 15–26.
3. 3 Bonnet, C.S., Walsh, D.A., Osteoarthritis, angiogenesis and inflammation. Rheumatol Oxf 44:1 (2005), 7–16.
4. 4 Sokolove, J., Lepus, C.M., Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 5:2 (2013), 77–94.
5. 5 Houard, X., Goldring, M.B., Berenbaum, F., Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep, 15(11), 2013, 375.
6. 6 Breedveld, F.C., Osteoarthritis–the impact of a serious disease. Rheumatol Oxf 43:Suppl 1 (2004), i4–i8.
7. 7 Steinert, A.F., Noth, U., Tuan, R.S., Concepts in gene therapy for cartilage repair. Injury 39:Suppl 1 (2008), S97–S113.
8. 8 Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.P., Fahmi, H., Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7:1 (2011), 33–42.
9. 9 Goldring, M.B., Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2:6 (2000), 459–465.
10. 10 Wojdasiewicz, P., Poniatowski, L.A., Szukiewicz, D., The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm, 2014, 2014, 561459.
11. 11 Bonizzi, G., Karin, M., The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:6 (2004), 280–288.
12. 12 Ding, G.J., Fischer, P.A., Boltz, R.C., Schmidt, J.A., Colaianne, J.J., Gough, A., et al. Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem 273:44 (1998), 28897–28905.
13. 13 Roman-Blas, J.A., Jimenez, S.A., NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 14:9 (2006), 839–848.
14. 14 Zoltick, P.W., Wilson, J.M., Regulated gene expression in gene therapy. Ann N Y Acad Sci 953 (2001), 53–63.
15. 15 Goldring, M.B., Anticytokine therapy for osteoarthritis. Expert Opin Biol Ther 1:5 (2001), 817–829.
16. 16 Liu-Bryan, R., Terkeltaub, R., Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 11:1 (2015), 35–44.
17. 17 Kawahara, T.L., Michishita, E., Adler, A.S., Damian, M., Berber, E., Lin, M., et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136:1 (2009), 62–74.
18. 18 Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J 23:12 (2004), 2369–2380.
19. 19 Matsushita, T., Sasaki, H., Takayama, K., Ishida, K., Matsumoto, T., Kubo, S., et al. The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1beta in human chondrocytes. J Orthop Res 31:4 (2013), 531–537.
20. 20 Takayama, K., Ishida, K., Matsushita, T., Fujita, N., Hayashi, S., Sasaki, K., et al. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 60:9 (2009), 2731–2740.
21. 21 Gagarina, V., Gabay, O., Dvir-Ginzberg, M., Lee, E.J., Brady, J.K., Quon, M.J., et al. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum 62:5 (2010), 1383–1392.
22. 22 Dvir-Ginzberg, M., Steinmeyer, J., Towards elucidating the role of SirT1 in osteoarthritis. Front Biosci (Landmark Ed) 18 (2013), 343–355.
23. 23 Filipowicz, W., Bhattacharyya, S.N., Sonenberg, N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 9:2 (2008), 102–114.
24. 24 Nugent, M., MicroRNAs: exploring new horizons in osteoarthritis. Osteoarthritis Cartilage, 2015.
25. 25 Marques-Rocha, J.L., Samblas, M., Milagro, F.I., Bressan, J., Martinez, J.A., Marti, A., Noncoding RNAs, cytokines, and inflammation-related diseases. Faseb J 29:9 (2015), 3595–3611.
26. 26 Gabay, O., Clouse, K.A., Epigenetics of cartilage diseases. Joint Bone Spine, 2015.
27. 27 Matsukawa, T., Sakai, T., Yonezawa, T., Hiraiwa, H., Hamada, T., Nakashima, M., et al. MicroRNA-125b regulates the expression of aggrecanase-1 (ADAMTS-4) in human osteoarthritic chondrocytes. Arthritis Res Ther, 15(1), 2013, R28.
28. 28 Akhtar, N., Rasheed, Z., Ramamurthy, S., Anbazhagan, A.N., Voss, F.R., Haqqi, T.M., MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 62:5 (2010), 1361–1371.
29. 29 Meng, F., Zhang, Z., Chen, W., Huang, G., He, A., Hou, C., et al. MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1beta-induced chondrocyte responses. Osteoarthritis Cartilage, 2016.
30. 30 Park, S.J., Cheon, E.J., Kim, H.A., MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1beta-induced catabolic effects in human articular chondrocytes. Osteoarthritis Cartilage 21:7 (2013), 981–989.
31. 31 Akhtar, N., Haqqi, T.M., MicroRNA-199a* regulates the expression of cyclooxygenase-2 in human chondrocytes. Ann Rheum Dis 71:6 (2012), 1073–1080.
32. 32 Rogers, E.L., Reynard, L.N., Loughlin, J., The role of inflammation-related genes in osteoarthritis. Osteoarthritis Cartilage 23:11 (2015), 1933–1938.
33. 33 Tomankova, T., Petrek, M., Gallo, J., Kriegova, E., MicroRNAs: emerging regulators of immune-mediated diseases. Scand J Immunol 75:2 (2012), 129–141.
34. 34 Gabay, O., Sanchez, C., Epigenetics, sirtuins and osteoarthritis. Joint Bone Spine 79:6 (2012), 570–573.
35. 35 Paik, S., Jung, H.S., Lee, S., Yoon, D.S., Park, M.S., Lee, J.W., miR-449a regulates the chondrogenesis of human mesenchymal stem cells through direct targeting of lymphoid enhancer-binding factor-1. Stem Cells Dev 21:18 (2012), 3298–3308.
36. 36 Lize, M., Pilarski, S., Dobbelstein, M., E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 17:3 (2010), 452–458.
37. 37 Zhang, H., Feng, Z., Huang, R., Xia, Z., Xiang, G., Zhang, J., MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1. Int J Oncol 45:5 (2014), 2143–2152.
38. 38 Kim, Y.H., Lee, J.W., Targeting of focal adhesion kinase by small interfering RNAs reduces chondrocyte redifferentiation capacity in alginate beads culture with type II collagen. J Cell Physiol 218:3 (2009), 623–630.
39. 39 Lianxu, C., Hongti, J., Changlong, Y., NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. Osteoarthritis Cartilage 14:4 (2006), 367–376.
40. 40 Kobayashi, M., Squires, G.R., Mousa, A., Tanzer, M., Zukor, D.J., Antoniou, J., et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 52:1 (2005), 128–135.
41. 41 Li, J., Huang, J., Dai, L., Yu, D., Chen, Q., Zhang, X., et al. miR-146a, an IL-1beta responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. Arthritis Res Ther, 14(2), 2012, R75.
42. 42 Yang, B., Kang, X., Xing, Y., Dou, C., Kang, F., Li, J., et al. Effect of microRNA-145 on IL-1beta-induced cartilage degradation in human chondrocytes. FEBS Lett 588:14 (2014), 2344–2352.
43. 43 Dai, L., Zhang, X., Hu, X., Zhou, C., Ao, Y., Silencing of microRNA-101 prevents IL-1beta-induced extracellular matrix degradation in chondrocytes. Arthritis Res Ther, 14(6), 2012, R268.
44. 44 Zhou, Y., Chen, Q., Qin, R., Zhang, K., Li, H., MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells. Tumour Biol 35:12 (2014), 12369–12378.
45. 45 Wei, B., Song, Y., Zhang, Y., Hu, M., microRNA-449a functions as a tumor-suppressor in gastric adenocarcinoma by targeting Bcl-2. Oncol Lett 6:6 (2013), 1713–1718.
46. 46 Ren, X.S., Yin, M.H., Zhang, X., Wang, Z., Feng, S.P., Wang, G.X., et al. Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. Cancer Lett 344:2 (2014), 195–203.
47. 47 Chen, H., Lin, Y.W., Mao, Y.Q., Wu, J., Liu, Y.F., Zheng, X.Y., et al. MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett 320:1 (2012), 40–47.
48. 48 Matsuzaki, T., Matsushita, T., Takayama, K., Matsumoto, T., Nishida, K., Kuroda, R., et al. Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann Rheum Dis 73:7 (2014), 1397–1404.